Alloplex Biotherapeutics
About:
Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.
Website: https://www.alloplexbio.com/
Top Investors: HanAll Biopharma, Daewoong Pharmaceutical
Description:
Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.
Total Funding Amount:
$21.2M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Founders:
Frank Borriello
Number of Employees:
1-10
Last Funding Date:
2023-02-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai